期刊
NANOPHOTONICS
卷 10, 期 12, 页码 3383-3389出版社
WALTER DE GRUYTER GMBH
DOI: 10.1515/nanoph-2021-0390
关键词
immunoediting; immunotherapy; metastatic cancers; nanotechnology; photonics; tumor microenvironment
资金
- U.S. National Institutes of Health [R01CA205348]
- Oklahoma Center for the Advancement of Science and Technology [HR16-085, HF20-019]
The combination of nanotechnology, photonics, and immunotherapy has the potential to significantly impact the field of cancer treatment by synergizing to regulate immune editing and the immune system. By combining different treatment modalities, it can provide long-term tumor-specific immunity, preventing tumor metastasis and recurrence.
Nanotechnology, photonics, and immunotherapy are far-reaching technologies with the potential to revolutionize the field of cancer diagnostics and therapeutics. While each technology has limitations in cancer treatment, they can be synergized to exert profound impact on the balance and modulation of immunoediting in tumor microenvironment (TME) and in the entire host immune system. We provide our perspectives on how nano-photoimmuno interactions can be used as an effective therapy, particularly when combined with other treatment modalities, such as checkpoint immune therapy, chemotherapy, and TME modulation, to provide a long-term, tumor-specific immunity against tumor metastasis and tumor recurrence.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据